Dasatinib - PDFSEARCH.IO - Document Search Engine

Dasatinib
Results: 118

#	Item
91	CLINICAL PRACTICE GUIDELINE LYHE-001 Management of Chronic Myeloid Leukemia Effective Date: November, 2012 The recommendations contained in this guideline are a consensus of the Alberta Provincial Hematology Tumour Add to Reading List Source URL: www.albertahealthservices.ca Language: English - Date: 2012-11-21 13:19:06 Medicine Piperazines Orphan drugs Pyridines Myeloid leukemia Chronic myelogenous leukemia Philadelphia chromosome Dasatinib Nilotinib Organic chemistry Chemistry Pyrimidines
92	Clinical Practice Guideline Add to Reading List Source URL: www.albertahealthservices.ca Language: English - Date: 2014-07-24 15:41:05 Myeloid leukemia Piperazines Organofluorides Acute leukemia Chronic myelogenous leukemia Philadelphia chromosome Acute myeloid leukemia Dasatinib Hematopoietic stem cell transplantation Medicine Oncology Pyrimidines
93	Qualifying Notice - Bosulif Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2014-07-09 10:48:30 Piperazines Orphan drugs Medicine Pyridines Organofluorides Chronic myelogenous leukemia Dasatinib Nilotinib Imatinib Organic chemistry Chemistry Pyrimidines
94	New Drug Application (NDA) & Biologic License Application (BLA) Efficacy Supplements (CY2010) Add to Reading List Source URL: www.fda.gov Language: English Amines Organochlorides Pharmaceutical industry Eli Lilly and Company Alcohols New Drug Application Darunavir Dasatinib Duloxetine Chemistry Organic chemistry Pharmacology
95	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG® (ponatinib) tablets for oral Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-12-23 15:37:55 Organochlorides Alkynes Organofluorides Ketorolac Syntex Ponatinib Stroke Clevidipine Dasatinib Chemistry Organic chemistry Piperazines
96	FDA Drug Safety Communication: FDA requires multiple new safety measures for leukemia drug Iclusig; company expected to resume marketing This information is in follow-up to the FDA Drug Safety Communication: FDA asks man Add to Reading List Source URL: www.fda.gov Language: English Medicine Pharmacology Pyrimidines Drug safety Orphan drugs Chronic myelogenous leukemia Food and Drug Administration Ponatinib Dasatinib Piperazines Chemistry Organic chemistry
97	Dasatinib for CML: Bench to ODAC Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Clinical research Health Pharmacology Drug safety Investigational New Drug Drug development New Drug Application Clinical trial Food and Drug Administration Research Pharmaceutical industry
98	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYNRIBO safely and effectively. See full prescribing information for SYNRIBO. ® Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-05-02 15:03:19 Orphan drugs Piperazines Pyrimidines Amines Anilides Omacetaxine mepesuccinate Chronic myelogenous leukemia Dasatinib Imatinib Chemistry Organic chemistry Medicine
99	Microsoft Word - bosulif_dhcpl_lapds_152211-eng.docx Add to Reading List Source URL: www.hc-sc.gc.ca Language: English - Date: 2014-07-09 10:48:30 Pyrimidines Pyridines Orphan drugs Organofluorides Dasatinib Imatinib Chronic myelogenous leukemia Philadelphia chromosome Nilotinib Organic chemistry Chemistry Piperazines
100	April[removed]Lists of medicinal products for rare diseases in Europe* Add to Reading List Source URL: www.orpha.net Language: English - Date: 2014-05-13 11:35:01 Piperazines Rare diseases Hepatology Orphanet European Medicines Agency Orphan drug Actelion Pulmonary hypertension Dasatinib Medicine Health Alcohols